- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1590-3478
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical characteristics of MOG antibody disease: two case reports ; day:10 ; month:2 ; year:2021 ; pages:1-7
Neurological sciences ; (10.2.2021), 1-7
- Urheber
-
Guan, Yujia
Zhang, Zunwei
Li, Mingming
Shi, Miao
Deng, Hui
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10072-021-05122-4
- URN
-
urn:nbn:de:101:1-2021033122161962396174
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guan, Yujia
- Zhang, Zunwei
- Li, Mingming
- Shi, Miao
- Deng, Hui
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neurological update: MOG antibody disease
MOG antibody-associated optic neuritis
Understanding MOG antibody-associated disease in Brazil
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
MOG antibody-associated encephalitis secondary to Covid-19: case report
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
Neurological update: MOG antibody disease
MOG antibody-associated optic neuritis
Understanding MOG antibody-associated disease in Brazil
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
MOG antibody-associated encephalitis secondary to Covid-19: case report
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
Neurological update: MOG antibody disease
MOG antibody-associated optic neuritis
Understanding MOG antibody-associated disease in Brazil
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
MOG antibody-associated encephalitis secondary to Covid-19: case report
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Challenging diagnosis of myelin oligodendrocyte glycoprotein (MOG) antibody: positive optic neuritis
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders